Skip to content
← Back to this collection

PUBLICATIONS · 18829514

A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2008 Oct 1
First author
Hensley ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hensley ML
      type
      Author
    2. name
      Larkin J
      type
      Author
    3. name
      Fury M
      type
      Author
    4. name
      Gerst S
      type
      Author
    5. name
      Tai DF
      type
      Author
    6. name
      Sabbatini P
      type
      Author
    7. name
      Konner J
      type
      Author
    8. name
      Orlando M
      type
      Author
    9. name
      Goss TL
      type
      Author
    10. name
      Aghajanian CA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hensley ML
      type
      Author
    2. name
      Larkin J
      type
      Author
    3. name
      Fury M
      type
      Author
    4. name
      Gerst S
      type
      Author
    5. name
      Tai DF
      type
      Author
    6. name
      Sabbatini P
      type
      Author
    7. name
      Konner J
      type
      Author
    8. name
      Orlando M
      type
      Author
    9. name
      Goss TL
      type
      Author
    10. name
      Aghajanian CA
      type
      Author
    bibliography ids
    1. nci-bib-f24737f3077e38abb1f0ff33
    book metadata
    content sha256
    d608c41706c500240aad13c151fb00d06bd6e88fabac9c1aee7e7470ade96667
    document type
    citation
    dois
    1. 10.1158/1078-0432.CCR-08-0338
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18829514
    immutable id
    pubmed:18829514@d608c41706c500240aad13c151fb00d06bd6e88fabac9c1aee7e7470ade96667
    journal
    abbreviation
    Clin Cancer Res
    issn electronic
    Source null
    issn print
    1078-0432
    issue
    19
    name
    Clinical cancer research : an official journal of the American Association for Cancer Research
    nlm unique id
    9502500
    pages
    6310-6
    volume
    14
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18829514
      provenance
      batch id
      6281e3e555c9a831cffc
      provider
      NCBI PubMed ESummary
      record sha256
      01bd810f826c5d1a5e0afcdbc878a5b577b5accd686ef729b9c4fbe60fd5c5be
      response sha256
      0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
      retrieved at
      2026-09-09T23:46:21.772457+00:00
      publication date
      display
      2008 Oct 1
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18829514/
      title
      A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.

      Preserved source evidence · Not medical advice